Science Stories

featured story

There were approximately 17-18 million new cancer cases diagnosed worldwide in 2018, of which about 7% – or 1.2 million people – were blood cancers. While tremendous progress in the treatment of these cancers has been made and survival rates for common blood cancers have consistently improved over time, there is still work to be done. Certain blood cancers, like acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL), can be more difficult to treat because they are rare and have a more aggressive nature.

Every three minutes, someone in the U.S. is diagnosed with a blood cancer. Fast-growing blood cancers like acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) can become life-threatening if left untreated because they can quickly spread to other parts of the body, including the brain and spinal cord. Hematopoietic stem cell transplantation (HSCT) can provide an important option in improving outcomes for appropriate patients.

In the treatment of cancer, one size does not fit all. At Jazz, our researchers are committed to discovering new possibilities for delivering innovative treatments as effectively and safely as possible.

Narcolepsy is an often misunderstood and under-recognized condition. Cataplexy is a major symptom of narcolepsy, a chronic neurological condition that involves other symptoms such as excessive daytime sleepiness – that can result in difficulty focusing and maintaining alertness, along with sleep paralysis and vivid hallucinations when falling asleep or waking up.